Acetylsalicylic acid in essential thrombocythemia
- PMID: 33537841
- DOI: 10.1007/s00508-021-01814-1
Acetylsalicylic acid in essential thrombocythemia
Comment on
-
Austrian recommendations for the management of essential thrombocythemia.Wien Klin Wochenschr. 2021 Jan;133(1-2):52-61. doi: 10.1007/s00508-020-01761-3. Epub 2020 Nov 19. Wien Klin Wochenschr. 2021. PMID: 33215234
References
-
- Pascale S, Petrucci G, Dragani A, et al. Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target. Blood. 2012;119(15):3595–603. - DOI
-
- Scavone M, Rizzo J, Femia EA, et al. Patients with essential thrombocythemia may be poor responders to enteric-coated aspirin, but not to plain aspirin. Thromb Haemost. 2020;120(10):1442–53. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
